European Archives - Page 458 of 1636 - European Medical Journal

Telerheumatology and eConsults: Bridging Gaps in Care

The electronic consultation (eConsult) is a structured, asynchronous communication tool that facilitates dialogue between primary care…

Updates From the EULAR 2025 Congress

THE European Alliance of Associations for Rheumatology (EULAR) 2025 Congress was held in Barcelona, Spain, from the…

Long-Term Selexipag for Digital Ulcers in Systemic Sclerosis

Digital ulcers (DU) affect approximately 50% of patients with systemic sclerosis (SSc), causing significant pain and…

Reference Values of Eosinophil-derived Neurotoxin in Blood

Eosinophil-derived neurotoxin (EDN), as a biomarker of eosinophilic activity, can be measured in blood matrices such…

Bi-directional HCP-patient communication

This symposium explored issues, guidance, and benefits associated with bi-directional HCP-patient communication, using hereditary angioedema consultations as an example.

How to Treat ANCA-Associated Vasculitis

IN A HIGHLY anticipated session presented at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, Benjamin…

Dual JAK/ROCK inhibition in Rheumatoid Arthritis

Despite various treatments, the first-line approach for rheumatoid arthritis (RA) has long relied on disease-modifying antirheumatic…

Immunodeficiencies, Allergies, Immune Dysregulation, and Lymphoproliferation: EAACI 2025

INBORN errors of immunity (IEI) are rare conditions caused by genetic factors that impair the development or function of the immune system…

Cancer Risk in Rheumatoid Arthritis: Insights from BIOBADASER III

Safety data on the use of biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) in patients…

Focus on Interdisciplinarity - Better Together: EAACI 2025

ASTHMA is an inflammatory airway disease with a high prevalence in many parts of the world. It is characterised by variable airway obstruction in…